We are live on ! Find out more
Natixis Advisors

Natixis Advisors Portfolio holdings

AUM $71.9B
1-Year Est. Return 28.03%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$12.2B
AUM Growth
+$822M
Cap. Flow
+$335M
Cap. Flow %
2.73%
Top 10 Hldgs %
14.79%
Holding
1,100
New
46
Increased
577
Reduced
433
Closed
42

Top Sells

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$22.6M
2
CLX icon
Clorox
CLX
+$15.2M
3
RITM icon
Rithm Capital
RITM
+$9.88M
4
APC
Anadarko Petroleum
APC
+$8.85M
5
STT icon
State Street
STT
+$8.55M

Sector Composition

Rank Sector Weight
1 Technology 15.6%
2 Financials 15.41%
3 Healthcare 12.01%
4 Consumer Discretionary 9.48%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$635B
$76.9M 0.63%
552,304
+37,899
+7% +$5.25M
ACN icon
27
Accenture
ACN
$89.9B
$75.6M 0.62%
408,992
+1,197
+0.3% +$215K
DE icon
28
Deere & Co
DE
$170B
$73.5M 0.6%
443,635
-2,848
-0.6% -$443K
EXPD icon
29
Expeditors International
EXPD
$22.9B
$73.3M 0.6%
965,938
-5,093
-0.5% -$384K
VTV icon
30
Vanguard Value ETF
VTV
$189B
$72.6M 0.59%
654,530
+182,717
+39% +$19.9M
BRK.B icon
31
Berkshire Hathaway Class B
BRK.B
$1.07T
$71.6M 0.58%
335,894
+14,035
+4% +$2.9M
MDT icon
32
Medtronic
MDT
$107B
$71.1M 0.58%
730,051
+45,798
+7% +$4.18M
VOE icon
33
Vanguard Mid-Cap Value ETF
VOE
$23.7B
$71.1M 0.58%
638,218
+19,732
+3% +$2.16M
SCZ icon
34
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
$69.6M 0.57%
1,212,558
+14,545
+1% +$840K
VSS icon
35
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
$68.2M 0.56%
648,245
+93,941
+17% +$9.8M
DIS icon
36
Walt Disney
DIS
$165B
$67.8M 0.55%
485,353
+47,012
+11% +$6.23M
EFA icon
37
iShares MSCI EAFE ETF
EFA
$76.4B
$65.7M 0.54%
999,516
+52,728
+6% +$3.45M
REGN icon
38
Regeneron Pharmaceuticals
REGN
$68.8B
$64.8M 0.53%
206,869
+471
+0.2% +$157K
VBK icon
39
Vanguard Small-Cap Growth ETF
VBK
$23.2B
$64.7M 0.53%
347,627
+15,784
+5% +$2.87M
VEA icon
40
Vanguard FTSE Developed Markets ETF
VEA
$226B
$64M 0.52%
1,533,254
+701,222
+84% +$28.9M
NVDA icon
41
NVIDIA
NVDA
$5.01T
$63.8M 0.52%
15,545,760
+1,083,320
+7% +$4.49M
CERN
42
DELISTED
Cerner Corp
CERN
$63.5M 0.52%
866,766
-8,079
-0.9% -$545K
MRK icon
43
Merck
MRK
$324B
$63.1M 0.52%
789,198
-95,984
-11% -$7.35M
TMO icon
44
Thermo Fisher Scientific
TMO
$211B
$62.9M 0.51%
214,074
+8,427
+4% +$2.32M
CVX icon
45
Chevron
CVX
$388B
$58M 0.47%
466,093
+84,681
+22% +$10.2M
PFE icon
46
Pfizer
PFE
$140B
$57.8M 0.47%
1,406,708
-24,194
-2% -$961K
SEIC icon
47
SEI Investments
SEIC
$11.9B
$56.3M 0.46%
1,003,945
-30,226
-3% -$1.63M
AMGN icon
48
Amgen
AMGN
$203B
$56M 0.46%
303,797
+569
+0.2% +$102K
YUM icon
49
Yum! Brands
YUM
$41B
$55M 0.45%
497,019
-1,406
-0.3% -$146K
CL icon
50
Colgate-Palmolive
CL
$72.6B
$54.1M 0.44%
754,583
+2,100
+0.3% +$149K

Similar funds

Natixis Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Natixis Advisors held 1,100 positions worth $12.2B, up 7.2% from $11.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Natixis Advisors's Q2 2019 filing shows 46 new, 577 increased, 433 reduced and 42 closed positions. Its largest new stake was Alcon: 306,725 shares worth $19M. The largest sale was Ecolab, an estimated $22.6M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Natixis Advisors's largest Q2 2019 buy was Alcon: 306,725 shares worth $19M.
  • Natixis Advisors added most to Vanguard FTSE Developed Markets ETF in Q2 2019, an estimated $28.9M increase.
  • Natixis Advisors's biggest Q2 2019 reduction was Ecolab, cutting an estimated $22.6M.
  • Natixis Advisors fully exited Clorox in Q2 2019, selling an estimated $15.2M.
  • Natixis Advisors's ten largest holdings make up 15% of its $12.2B portfolio in Q2 2019.
  • Natixis Advisors opened 46 new positions and closed 42 in Q2 2019.
  • Natixis Advisors's portfolio value rose 7.2% quarter-over-quarter to $12.2B.

Based on Natixis Advisors's 13F filing for Q2 2019, filed 12 Aug 2019.